Memantine for the patients with mild cognitive impairment in Parkinson's disease: a pharmacological fMRI study. Alzforum, 20 May 2022 Kawashima S, RCIP-Nagoya Study Group, Matsukawa N. BMC Neurol. 2022 May 13;22(1):175.